Technical Analysis for ONCS - OncoSec Medical Incorporated

Grade Last Price % Change Price Change
grade F 2.2 2.33% 0.05
ONCS closed up 2.33 percent on Friday, September 20, 2019, on 30 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ONCS trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
50 DMA Support Bullish 2.33%
Upper Bollinger Band Walk Strength 2.33%
MACD Bullish Centerline Cross Bullish -0.45%
Stochastic Reached Overbought Strength -0.45%
Upper Bollinger Band Walk Strength -0.45%
Weak + Overbought Other -0.45%
Overbought Stochastic Strength -0.45%

Older signals for ONCS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
OncoSec Medical Incorporated, a hybrid device and gene therapy biotechnology company, designs, develops, and commercializes medical approaches principally immunotherapy for the treatment of solid tumors in the United States. Its clinical programs include three Phase II clinical trials to assess the ImmunoPulse technology in patients with melanoma, Merkel cell carcinoma, and cutaneous T-cell lymphoma. It has a collaboration agreement with Heat Biologics, Inc. to evaluate the combination of immunotherapy platforms. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated is headquartered in San Diego, California.
Medicine Biotechnology Biology Solid Tumors Immunotherapy Cancer Treatments Gene Therapy Virotherapy Melanoma Genetic Engineering Cutaneous T Cell Lymphoma Heat Biologics Merkel Cell Carcinoma
Is ONCS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.6
52 Week Low 1.8
Average Volume 84,108
200-Day Moving Average 4.5393
50-Day Moving Average 2.1144
20-Day Moving Average 2.0285
10-Day Moving Average 2.098
Average True Range 0.1616
ADX 16.51
+DI 22.1787
-DI 17.9769
Chandelier Exit (Long, 3 ATRs ) 1.9052
Chandelier Exit (Short, 3 ATRs ) 2.2848
Upper Bollinger Band 2.2574
Lower Bollinger Band 1.7996
Percent B (%b) 0.87
BandWidth 22.5684
MACD Line 0.021
MACD Signal Line -0.0163
MACD Histogram 0.0373
Fundamentals Value
Market Cap 46.57 Million
Num Shares 21.2 Million
EPS -1.14
Price-to-Earnings (P/E) Ratio -1.93
Price-to-Sales 0.00
Price-to-Book 1.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.35
Resistance 3 (R3) 2.34 2.29 2.33
Resistance 2 (R2) 2.29 2.25 2.29 2.32
Resistance 1 (R1) 2.24 2.22 2.27 2.25 2.31
Pivot Point 2.19 2.19 2.20 2.19 2.19
Support 1 (S1) 2.14 2.15 2.17 2.15 2.09
Support 2 (S2) 2.09 2.12 2.09 2.08
Support 3 (S3) 2.04 2.09 2.08
Support 4 (S4) 2.05